Grifols shares jump after report on takeover talks resuming
Shares in Grifols jumped sharply on Wednesday morning after news website El Confidencial reported that Canadian fund ...
Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors
This was the stock's fifth consecutive day of losses.
Analysts Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Price Target at $59.13
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) has received a consensus rating of “Buy” from the ten ...
Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors
This was the stock's fourth consecutive day of losses.
65 Equity Makes Europe Foray With Swiss Pharma Merger
Asset manager 65 Equity Partners is backing Swiss pharmaceutical ingredient maker Healthcare Advanced Synthesis SA’s ...
Finanznachrichten4d
Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities
Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report 13.03. Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering ...
Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation [...]
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), an oncology and obesity company with a diversified portfolio, announced today the dosing of the first subject in the ...
Corbus announces first patient dosed in Phase 1 CRB-913 study
Corbus Pharmaceuticals (CRBP) announced the dosing of the first subject in the single ascending dose / multiple ascending dose portion of the ...
Investing14d
Corbus Pharmaceuticals appoints new COO
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), a biopharmaceutical company with a market capitalization of $77 million, announced on Monday the appointment of Ian Hodgson as the new Chief ...